Delivery Order SPE2DB20D1109-SPE2DB25FP40R
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imitrex 6 mg/0.5 mL pen injectors, a prescription migraine medication. The contract has a firm fixed price and a ceiling value of $10,429.34. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a $1,780.84 firm-fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imitrex 6 mg/0.5 ml pen injectors, a prescription medication used to treat migraines. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,798.64. The contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraine headaches. The contract is not set aside and is a firm fixed price delivery order with a completion date of June 18, 2025. AmerisourceBergen Drug Corp is the prime contractor and is a for-profit...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Imitrex 6 mg/0.5 ml pen injectors (0.5 ml) to support government healthcare programs. The contract has a ceiling value of $1,476.05 and is a firm fixed-price delivery order with a period of performance through May 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,373.47 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The order has an ultimate completion date of October 27, 2023. Amerisourcebergen is the prime contractor, and there is no set-aside designation, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The contract has a ceiling value of $1,043.43 and a period of performance extending through July 3, 2025. The contract is not set-aside and is a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,166.58 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has a firm fixed price of $1,017.73 and a completion date of July 3, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,488.93, is for the delivery of Imitrex 6 mg/0.5 ml pen injectors. The contract is a firm-fixed price arrangement and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has a ceiling value of $1,699.10 and a period of performance through July 3, 2025. This is a non-set-aside contract, meaning it was open to general competition. AmerisourceBergen Drug Corp also holds a significant...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP40RDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Imitrex 6 mg/0.5 ml pen injectors, a medication used to treat migraines. The contract has a ceiling value of $1,593.35 and is a firm fixed-price delivery order, which means the price per unit is predetermined. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/16/25 |